These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8790501)

  • 1. Using economics to assess the place of screening.
    Donaldson C
    J Med Screen; 1994 Apr; 1(2):124-8; discussion 128-9. PubMed ID: 8790501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluations of screening programs: a review of methods and results.
    Butler JR
    Clin Chim Acta; 2002 Jan; 315(1-2):31-40. PubMed ID: 11728408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for thalassemia: an economics viewpoint.
    Indaratna K
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():75-81. PubMed ID: 9640604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis.
    Danese MD; Powe NR; Sawin CT; Ladenson PW
    JAMA; 1996 Jul 24-31; 276(4):285-92. PubMed ID: 8656540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of implementation of the Clinical Laboratory Improvement Amendments of 1988--the example of pediatric office-based cholesterol screening.
    Tershakovec AM; Brannon SD; Bennett MJ; Shannon BM
    Pediatrics; 1995 Aug; 96(2 Pt 1):230-4. PubMed ID: 7630675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teaching health economics: some guidelines arising from a WHO workshop.
    Drummond MF; Mooney GH; Zöllner HF
    Eff Health Care; 1983 Oct; 1(3):165-73. PubMed ID: 10310265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do we evaluate the economics of health care?
    Kumar S; Williams AC; Sandy JR
    Eur J Orthod; 2006 Dec; 28(6):513-9. PubMed ID: 17035484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economics of prostate cancer screening.
    Benoit RM; Naslund MJ
    Oncology (Williston Park); 1997 Oct; 11(10):1533-43; discussion 1543, 1547-8. PubMed ID: 9348558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs.
    Rasmussen SR; Thomsen JL; Kilsmark J; Hvenegaard A; Engberg M; Lauritzen T; Søgaard J
    Scand J Public Health; 2007; 35(4):365-72. PubMed ID: 17786799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of work-site cholesterol screening and intervention programs.
    Wilson MG; Edmunson J; DeJoy DM
    J Occup Med; 1992 Jun; 34(6):642-9. PubMed ID: 1619496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health economics in developing countries.
    Abel-Smith B
    J Trop Med Hyg; 1989 Aug; 92(4):229-41. PubMed ID: 2503621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics of cancer screening: total costs and benefits in economic terms.
    Pedersen KM
    Eur J Cancer; 1994; 30A(6):879-84. PubMed ID: 7917552
    [No Abstract]   [Full Text] [Related]  

  • 15. [Health economics analysis of cervical cancer screening].
    Boncz I; Sebestyén A; Pál M; Sándor J; Ember I
    Orv Hetil; 2003 Apr; 144(15):713-7. PubMed ID: 12774432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost comparison of different methods of screening for cystic fibrosis.
    Morris JK; Oppenheimer PM
    J Med Screen; 1995; 2(1):22-7. PubMed ID: 7497140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis.
    Maxwell S; Brameld K; Youngs L; Geelhoed E; O'Leary P
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):51-9. PubMed ID: 20218998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography screening: prospects and opportunity costs.
    Navarro AM; Kaplan RM
    Womens Health; 1996; 2(4):209-33. PubMed ID: 9421557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of cystic fibrosis screening: a review of the literature.
    Radhakrishnan M; van Gool K; Hall J; Delatycki M; Massie J
    Health Policy; 2008 Feb; 85(2):133-47. PubMed ID: 17728003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not just about costs: the role of health economics in facilitating decision making in aged care.
    Ratcliffe J; Laver K; Couzner L; Cameron ID; Gray L; Crotty M
    Age Ageing; 2010 Jul; 39(4):426-9. PubMed ID: 20444804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.